GlassScriptPhysician profile
Christine Tat
NPI 1447677315
$8,086.20
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.52 · 2021: $84.53 · 2022: $7,915.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,842.34 | 2022 | |
| Boston Scientific Corporation | $86.52 | 2019 | |
| Novo Nordisk INC | $77.58 | 2021-2022 | |
| Medtronic, INC. | $19.91 | 2021 | |
| Innocoll Pharmaceuticals Limited | $16.45 | 2021 | |
| Eagle Pharmaceuticals, INC. | $15.19 | 2022 | |
| Redhill Biopharma INC. | $14.56 | 2021 | |
| Vivus LLC | $13.65 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Tat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.